RISANKIZUMAB VS USTEKINUMAB NEL CROHN. IL GRANDE TRIAL MULTICENTRICO “SEQUENCE”. NELLA REMISSIONE ENDOSCOPICA VINCE RISANKIZUMAB. DA “NEJM”

ENDOSCOPIA, GASTROENTEROLOGIA, IBD, NEWSLETTER, Senza categoria

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease L. Peyrin-Biroulet et al for the SEQUENCE Study Group. Abstract The efficacy and safety of risankizumab as compared with ustekinumab in patients with Crohn’s disease are unknown. METHODS In this phase 3b, multicenter, open-label, randomized, controlled trial with blinded assessment of end points, patients with moderate-to-severe Crohn’s disease…

CANCRO DELLO STOMACO E MICROBIOTA. UNA GRANDE REVISIONE ED UNO SGUARDO AL FUTURO. DA “GUT” (FREE)

CHIRURGIA, DIAGNOSTICA PER IMMAGINI, ENDOSCOPIA, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, NEWSLETTER, ONCOLOGIA, Senza categoria

Stomach microbiota in gastric cancer development and clinical implications Ruijie Zeng et al. Abstract Gastric cancer (GC) is one of the most common malignancies and a prominent cause of cancer mortality worldwide. A distinctive characteristic of GC is its intimate association with the commensal microbial community. Although Helicobacter pylori is widely recognised as an inciting factor…

PANCREATITE ACUTA SEVERA. NUTRIZIONE VIA SONDINO GASTRICO O DUODENALE ? NON SONO UGUALI PER SOLLIEVO DOLORE, INFEZIONI INDOTTE E DIARREA. UNA META-ANALISI DA ” BMC GASTROENTEROLOGY” (FREE)

CHIRURGIA, GASTROENTEROLOGIA, NEWSLETTER, NUTRIZIONE, PANCREAS E VIE BILIARI, Senza categoria

Comparative safety assessment of nasogastric versus nasojejunal feeding initiated within 48 hours post-admission versus unrestricted timing in moderate or severe acute pancreatitis: a systematic review and meta-analysis Ming Wang et al.   Abstract Background The primary objective of this study is to comparatively assess the safety of nasogastric (NG) feeding versus nasojejunal (NJ) feeding in…

NEOPLASIE MUCINOSE INTRADUTTALI DEL PANCREAS: MA ALLORA IL MICROBIOMA NON E’ CORRESPONSABILE? DA “GUT” (FREE)

CHIRURGIA, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, NEWSLETTER, ONCOLOGIA, PANCREAS E VIE BILIARI, Senza categoria

Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm   Marie-Madlen Pust et al. Abstract Objective This study aims to validate the existence of a microbiome within intraductal papillary mucinous neoplasm (IPMN) that can be differentiated from the taxonomically diverse DNA background of next-generation sequencing procedures. Design We generated 16S rRNA amplicon sequencing data to analyse…

BREAKING NEWS DALLA DDW MAGGIO 2024 : L’USO DELLE STATINE PROTEGGE DALLO SVILUPPO DI PSC (colangite sclerosante primitiva) NELLE IBD? DA “GI & HEPATOLOGY NEWS” (AN AGA INITIATIVE) (FREE)

DIAGNOSTICA PER IMMAGINI, EPATOLOGIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, IBD, NEWSLETTER, Senza categoria

In IBD Patients, Statin Use Associated with Lower Risk of Developing PSC By Carolyn Crist WASHINGTON – Secondo uno studio presentato alla Digestive Disease Week® (DDW) 2024, l’uso di statine può contribuire a ridurre significativamente il rischio di nuova colangite sclerosante primaria (PSC) tra i pazienti affetti da malattie infiammatorie intestinali (IBD). L’uso di statine è…

GIST (GASTROINTESTINAL STROMAL TUMOR): NUOVA LINEA GUIDA INGLESE ! DA “BRITISH JOURNAL OF CANCER” (FREE)

CHIRURGIA, GASTROENTEROLOGIA, LINEE GUIDA EBM, NEWSLETTER, ONCOLOGIA, Senza categoria

Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines Ian Judson et al. BACKGROUND: British Sarcoma Group guidelines for the management of GIST were initially informed by those published by the European Society of Clinical Oncology. This update was written by a group of experts to includes a discussion of the highlight improvements in…